Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and Criteria for Categorisation of Medicines

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Documents

Date Added: 27 - Apr - 2022

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of PITOLISANT HYDROCHLORIDE film-coated tablets (Ozawade®) for treating excessive daytime sleepiness caused by obstructive sleep apnoea, in accordance with NICE TA776.

Body System:
Date Added: 26 - May - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of PITOLISANT tablets (Wakix®▼), by specialists working in a regional and national tertiary commissioned sleep service only, for the treatment of narcolepsy with or without cataplexy in adult patients in accordance with the Aintree University Hospital Sleep Service Pathway for Narcolepsy.

Black NHS West Lancashire CCG

Body System: